MODERNIZING U.S. BIOTECHNOLOGY REGULATION WITH STAKEHOLDER INSIGHTS
NSCEB invites input on statutory amendments to enable simple regulatory pathways and accelerate innovation
1 July 2025
The National Security Commission on Emerging Biotechnology (NSCEB) is gathering input to modernize U.S. biotechnology product regulation and create simpler, faster, science-based pathways to market. This input will guide follow-on work to the Commission’s April 2025 report, which called for streamlining regulation of biotechnology products.
NSCEB staff are seeking concrete, actionable ideas across sectors, including defense, industrial products, food, agriculture, and healthcare. We ask interested parties to share their ideas for statutory reform via the survey links below by July 16, 2025. NSCEB staff will also hold consultations and listening sessions.
- The survey for industrial, food, agricultural, and other products is at https://forms.office.com/g/xCvb9Sjv3v, with the full list of questions here [pdf].
- The survey for pharmaceutical products is at https://forms.office.com/g/UzuXTfRcEq, with the full list of questions here [pdf].
About NSCEB: The National Security Commission on Emerging Biotechnology is a time-limited, high-impact legislative branch advisory entity whose purpose is to advance and secure biotechnology, biomanufacturing, and associated technologies for U.S. national security and to prepare the United States for the bioindustrial revolution. The Commission published a comprehensive report in April 2025, including recommendations for action by Congress and the federal government. The bipartisan Commission is composed of Congressionally-appointed Commissioners with members from both the Senate and the House of Representatives as well as experts from industry, academia, and government. For more information about the Commission and to view the report, visit biotech.senate.gov.
Contact: ideas@biotech.senate.gov
